Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with <scp>MDS</scp>/<scp>AML</scp> or <scp>AML</scp>

Corentin Orvain, Naveed Ali, Megan Othus, Eduardo Rodríguez‐Arbolí, Filippo Milano, Calvin M. Le, Brenda M. Sandmaier, Bart L. Scott, Frederick R. Appelbaum, Roland B. Walter

Open source

DOI
10.1002/ajh.27259
Published
2024-02-21
Container
American Journal of Hematology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ajh.27259,
  title = {Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with <scp>MDS</scp>/<scp>AML</scp> or <scp>AML</scp>},
  author = {Corentin Orvain and Naveed Ali and Megan Othus and Eduardo Rodríguez‐Arbolí and Filippo Milano and Calvin M. Le and Brenda M. Sandmaier and Bart L. Scott and Frederick R. Appelbaum and Roland B. Walter},
  year = {2024},
  journal = {American Journal of Hematology},
  doi = {10.1002/ajh.27259},
  url = {https://doi.org/10.1002/ajh.27259}
}

RIS

TY  - JOUR
TI  - Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with <scp>MDS</scp>/<scp>AML</scp> or <scp>AML</scp>
AU  - Corentin Orvain
AU  - Naveed Ali
AU  - Megan Othus
AU  - Eduardo Rodríguez‐Arbolí
AU  - Filippo Milano
AU  - Calvin M. Le
AU  - Brenda M. Sandmaier
AU  - Bart L. Scott
AU  - Frederick R. Appelbaum
AU  - Roland B. Walter
PY  - 2024
JO  - American Journal of Hematology
DO  - 10.1002/ajh.27259
UR  - https://doi.org/10.1002/ajh.27259
ER  - 

APA

Orvain, C., Ali, N., Othus, M., Rodríguez‐Arbolí, E., Milano, F., Le, C. M., Sandmaier, B. M., Scott, B. L., Appelbaum, F. R., & Walter, R. B. (2024). Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with <scp>MDS</scp>/<scp>AML</scp> or <scp>AML</scp>. American Journal of Hematology. https://doi.org/10.1002/ajh.27259

Source records